Literature DB >> 15905643

Chromosomal aberrations involving telomeres in BRCA1 deficient human and mouse cell lines.

S Al-Wahiby1, P Slijepcevic.   

Abstract

Cells defective in BRCA1 show genomic instability as evidenced by increased radiosensitivity, the presence of chromosomal abnormalities and the loss of heterozygosity at many loci. Reported chromosomal abnormalities in BRCA1 deficient cells include dicentric chromosomes. Dicentric chromosomes, in some cases, may arise as a result of end-to-end chromosome fusions, which represent signatures of telomere dysfunction. In this study we examined BRCA1 deficient human and mouse cells for the presence of chromosomal aberrations indicative of telomere dysfunction. We identified a lymphoblastoid cell line, GM14090, established from a BRCA1 carrier that showed elevated levels of dicentric chromosomes. Molecular cytogenetic analysis revealed that these dicentric chromosomes result from end-to-end chromosome fusions. The frequency of end-to-end chromosome fusions did not change after exposure of GM14090 cells to bleomycin but we observed elevated levels of chromosomal abnormalities involving interactions between DNA double strand breaks and uncapped telomeres in this cell line. We observed similar chromosomal abnormalities involving telomeres in the breast cancer cell line, HCC1937, homozygous for BRCA1 mutation. Finally, we analyzed mouse embryonic stem cells lacking functional Brca1 and observed the presence of telomere dysfunction following exposure of these cells to bleomycin. Our results reveal cytogenetic evidence of telomere dysfunction in BRCA1 deficient cells. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905643     DOI: 10.1159/000084208

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  8 in total

Review 1.  Telomere biology: integrating chromosomal end protection with DNA damage response.

Authors:  Predrag Slijepcevic; Suliman Al-Wahiby
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

2.  BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage.

Authors:  Rahul D Ballal; Tapas Saha; Saijun Fan; Bassam R Haddad; Eliot M Rosen
Journal:  J Biol Chem       Date:  2009-09-21       Impact factor: 5.157

3.  BRCA1 in the DNA damage response and at telomeres.

Authors:  Eliot M Rosen
Journal:  Front Genet       Date:  2013-06-21       Impact factor: 4.599

4.  Defective Artemis causes mild telomere dysfunction.

Authors:  Hemad Yasaei; Predrag Slijepcevic
Journal:  Genome Integr       Date:  2010-05-26

Review 5.  Ubiquitination and SUMOylation in Telomere Maintenance and Dysfunction.

Authors:  Zeliha Yalçin; Carolin Selenz; Jacqueline J L Jacobs
Journal:  Front Genet       Date:  2017-05-23       Impact factor: 4.599

6.  A two-step mechanism for TRF2-mediated chromosome-end protection.

Authors:  Keiji Okamoto; Cristina Bartocci; Iliana Ouzounov; Jolene K Diedrich; John R Yates; Eros Lazzerini Denchi
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

7.  Analysis of alternative lengthening of telomere markers in BRCA1 defective cells.

Authors:  Parisa K Kargaran; Hemad Yasaei; Sara Anjomani-Virmouni; Giovanna Mangiapane; Predrag Slijepcevic
Journal:  Genes Chromosomes Cancer       Date:  2016-07-26       Impact factor: 5.006

8.  Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status.

Authors:  Karen A Pooley; Lesley McGuffog; Daniel Barrowdale; Debra Frost; Steve D Ellis; Elena Fineberg; Radka Platte; Louise Izatt; Julian Adlard; Julian Bardwell; Carole Brewer; Trevor Cole; Jackie Cook; Rosemarie Davidson; Alan Donaldson; Huw Dorkins; Fiona Douglas; Jacqueline Eason; Catherine Houghton; M John Kennedy; Emma McCann; Zosia Miedzybrodzka; Alex Murray; Mary E Porteous; Mark T Rogers; Lucy E Side; Marc Tischkowitz; Lisa Walker; Shirley Hodgson; Diana M Eccles; Patrick J Morrison; D Gareth Evans; Rosalind A Eeles; Antonis C Antoniou; Douglas F Easton; Alison M Dunning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-18       Impact factor: 4.254

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.